HYPER- AND HYPOCALCEMIA: PATHOGENESIS AND TREATMENTS
- 1 March 1974
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 230 (1 Paraneop) , 181-186
- https://doi.org/10.1111/j.1749-6632.1974.tb14446.x
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- EVIDENCE THAT THE BONE RESORPTION-STIMULATING FACTOR PRODUCED BY MOUSE FIBROSARCOMA CELLS IS PROSTAGLANDIN E2The Journal of Experimental Medicine, 1972
- DISTINCTIVE TUMOURS OF BONE AND SOFT TISSUE CAUSING ACQUIRED VITAMIN-D-RESISTANT OSTEOMALACIAThe Lancet, 1972
- Immunologic differentiation of primary hyperparathyroidism from hyperparathyroidism due to nonparathyroid cancerJournal of Clinical Investigation, 1971
- Some thoughts on the nature of ectopic parathyroid hormonesThe American Journal of Medicine, 1971
- PROSTAGLANDIN SECRETION BY MEDULLARY CARCINOMA OF THE THYROID: A Possible Cause of the Associated DiarrhoeaThe Lancet, 1968
- Parathyroid Hormone in Plasma in Adenomatous Hyperparathyroidism, Uremia, and Bronchogenic CarcinomaScience, 1966
- Cortisone in the treatment of hypercalcemia in neoplastic diseaseCancer, 1958
- Case 27461New England Journal of Medicine, 1941
- THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST.The Lancet, 1889
- Kalk-MetastasenVirchows Archiv, 1855